Our providers review your medical history, medications, previous treatments, wellness goals, and potential contraindications before discussing whether peptide therapy may be appropriate
The 2022 tirzepatide study demonstrated an average body weight reduction of 20% in obese individuals over 72 weeks on maximum dose of tirzepatide
References Jiang F, Wu Y, Liu Z, Hong M, Huang Y
The primary difference between compounded semaglutide and Ozempic is how they are made and regulated
Maximum: Up to roughly 4.5 mg weekly in advanced protocols, the dose tied to the greatest weight loss in early trials [4]
Semaglutide authorised as Ozempic is not currently recognised by regulators as causing specific vulvovaginal adverse reactions such as vaginal dryness, vulvovaginal candidiasis, altered discharge, dyspareunia, vaginal atrophy, or vaginal mucosal injury